Clinical Trial Update: PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN [Phase 2]

View source ↗

Summary

Phase II, single-center randomized open-label trial evaluating the impact of serial procalcitonin measurements in patients with hematologic malignancies and sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2024-03-12